Michele Walsh, MD
- Division Chief, Neonatology
- Division Chief, Neonatology
- William and Lois Briggs Chair in Neonatology
Michele Walsh, MD, FAAP, is Chief, Division of Neonatology and Perinatal Medicine and Inaugural William and Lois Briggs Endowed Chair in Neonatology at University Hospitals Rainbow Babies & Children’s Hospital and Chief, Division of Neonatology, UH Cleveland Medical Center. She is also Professor of Pediatrics, Case Western Reserve University School of Medicine.
Dr. Walsh is board certified in pediatrics and neonatal-perinatal medicine. Her special interest is in neonatal lung disease, clinical trials and quality improvement.
Dr. Walsh earned a bachelor’s degree summa cum laude from University of California, Davis, Calif. She received her medical degree from Case Western Reserve University School of Medicine where she was elected to Alpha Omega Alpha Honor Medical Society. Dr. Walsh completed her residency in pediatrics and a fellowship in neonatal-perinatal medicine, both at UH Rainbow Babies & Children’s Hospital. She joined the UH Rainbow Babies & Children’s Hospital staff in 1988.
In 2000 Dr. Walsh earned a Master’s of Science in epidemiology from the Case Western Reserve University School of Medicine; in 2007 she received a certificate from Harvard University, Cambridge, Mass., in Leadership Development for Physicians; and in 2012 she earned a certificate from University Hospitals Leadership Academy, Weatherhead School of Management, Case Western Reserve University.
Dr. Walsh is a dedicated researcher and has participated in a number of multi-center studies, primarily focusing on improving outcomes in neonates and premature infants. Currently she is participating in numerous studies, including serving as Principal Investigator on studies sponsored by the National Institute of Child Health and Human Development and the Ohio Children’s Hospitals' Neonatal Research Consortium.
She is a frequent invited presenter at local, national and international medical conferences, speaking on the diagnosis and management of medical problems in neonates and premature infants. She has authored or coauthored nearly 150 papers and abstracts in leading medical journals and three dozen monographs and chapters in textbooks. She is a reviewer for many prestigious pediatric journals, including Journal of Pediatrics, Pediatrics and Pediatric Research as well as American Journal of Epidemiology and Journal of the American Medical Association.
Dr. Walsh is a Fellow of the American Academy of Pediatrics and the American College of Physician Executives and a member of the American Pediatric Society. She has been named numerous times to America’s Top Pediatricians by the Consumers’ Research Council of America, Washington, DC; Cleveland’s Top Doctors and Who’s Who in America.
Awards and Recognition
Fellow, American Academy of Pediatrics
Fellow, American College of Physician Executives
America’s Top Pediatricians, Consumers’ Research Council of America
Cleveland’s Top Doctors
Improving outcomes in neonates and premature infants
- Health Services Research
- Neonatal Lung Disease
- Quality Improvement
Patient Satisfaction Reviews
0 out of 5
- Neonatal/Perinatal Medicine - American Board of Pediatrics
- Pediatrics - American Board of Pediatrics
Fellowship | Neonatal-Perinatal Medicine
Neonatal-Perinatal Medicine - University Hospitals Of Cleveland (1985 - 1987)
Residency | Pediatrics
Pediatrics - University Hospitals Of Cleveland (1983 - 1985)
Internship | Pediatrics
Pediatrics - University Hospitals Of Cleveland (1982 - 1983)
Case Western Reserve University School Of Medicine (1978 - 1982)
Case Western Reserve University School Of Medicine (2000)
University Of California Davis (1978)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Michele Walsh did not disclose any Outside Relationships with Industry.